Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

October 1, 2021

Study Completion Date

April 1, 2022

Conditions
Cholangitis, Secondary BiliaryTreatment ComplianceAntibodies Drug Specific
Interventions
DRUG

Sulperazon

moderate cholangitis patients were treated with these drugs for 7days,unless the patients were cured or must be changed the therapeutic.

DRUG

Teicoplanin

severe cholangitis patients were treated with these drugs for 7days,unless the patients were cured or must be changed the therapeutic.

DRUG

Meropenem Injection

cholangitis in control group were treated with these drugs for 7days,unless the patients were cured or must be changed the therapeutic.

Trial Locations (2)

430030

Tongji hospital affiliated to tongji medical college of huazhong university of science and technology, Wuhan

TongjiHospital, Wuhan

All Listed Sponsors
collaborator

Shanghai Children's Hospital

OTHER

lead

Tongji Hospital

OTHER